Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 14, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 148
- −12 vs. Q4 2024
- Portfolio value
- $4.46B
- −$732.1M (−14.1%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TEMTempus AI, Inc. | CL A | 237 | $11.4K | <0.1% | 00.0% | Unchanged | History |
| MTDMettler Toledo International Inc | COM | 42 | $49.6K | <0.1% | 00.0% | Unchanged | History |
| BIIBBiogen Inc. | COM | 402 | $55.0K | <0.1% | −2,250−84.8% | Reduced | History |
| QCOMQualcomm Inc | Stock | 447 | $68.7K | <0.1% | 00.0% | Unchanged | History |
| MSFTMicrosoft Corp | Stock | 203 | $76.2K | <0.1% | 00.0% | Unchanged | History |
| NVDANVIDIA Corp | Stock | 751 | $81.4K | <0.1% | 00.0% | Unchanged | History |
| ORCLOracle Corp | Stock | 654 | $91.4K | <0.1% | 00.0% | Unchanged | History |
| AAgilent Technologies, Inc. | COM | 806 | $94.3K | <0.1% | 00.0% | Unchanged | History |
| BRBRBellring Brands, Inc. | Stock | 1,400 | $104.2K | <0.1% | +1,400 | New | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 3,000 | $117.2K | <0.1% | −1,400−31.8% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 3,741 | $150.4K | <0.1% | −7,200−65.8% | Reduced | History |
| GOOGLAlphabet Inc. | Stock | 1,100 | $170.1K | <0.1% | +1,100 | New | History |
| AMZNAmazon Com Inc | Stock | 900 | $171.2K | <0.1% | +900 | New | History |
| BIDUBaidu, Inc. | ADR | 2,000 | $184.1K | <0.1% | 00.0% | Unchanged | History |
| GRMNGarmin Ltd | SHS | 850 | $184.6K | <0.1% | −200−19.0% | Reduced | History |
| PTCTPTC Therapeutics, Inc. | COM | 3,800 | $193.6K | <0.1% | 00.0% | Unchanged | History |
| ACLXArcellx, Inc. | COMMON STOCK | 3,000 | $196.8K | <0.1% | 00.0% | Unchanged | History |
| QUREuniQure N.V. | SHS | 22,500 | $238.5K | <0.1% | 00.0% | Unchanged | History |
| MLYSMineralys Therapeutics, Inc. | COM | 16,499 | $262.0K | <0.1% | 00.0% | Unchanged | History |
| OCSOculis Holding AG | ORDINARY SHARES | 14,100 | $268.3K | <0.1% | +4,100+41.0% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 1,900 | $296.1K | <0.1% | −600−24.0% | Reduced | History |
| EXELExelixis, Inc. | COM | 8,500 | $313.8K | <0.1% | +8,500 | New | History |
| ADMAAdma Biologics, Inc. | COM | 16,900 | $335.3K | <0.1% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 8,000 | $336.7K | <0.1% | 00.0% | Unchanged | History |
| BBIOBridgeBio Pharma, Inc. | COM | 10,400 | $359.5K | <0.1% | 00.0% | Unchanged | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 1,100 | $364.4K | <0.1% | 00.0% | Unchanged | History |
| TVTXTravere Therapeutics, Inc. | COM | 23,100 | $414.0K | <0.1% | 00.0% | Unchanged | History |
| PCVXVaxcyte, Inc. | COM | 11,290 | $426.3K | <0.1% | −748−6.2% | Reduced | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 28,930 | $444.7K | <0.1% | −31,668−52.3% | Reduced | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 21,800 | $446.2K | <0.1% | −3,200−12.8% | Reduced | History |
| iShares Russell 2000 ETF464287655 | ETF | 2,300 | $458.8K | <0.1% | +2,300 | New | – |
| KRYSKrystal Biotech, Inc. | COM | 2,650 | $477.8K | <0.1% | −2,397−47.5% | Reduced | History |
| ZTSZoetis Inc. | Stock | 3,114 | $512.7K | <0.1% | −6,665−68.2% | Reduced | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 35,700 | $558.3K | <0.1% | −3,800−9.6% | Reduced | History |
| ZLABZai Lab Ltd | ADR | 20,000 | $722.8K | <0.1% | +7,000+53.8% | Added | History |
| BNTXBioNTech SE | SPONSORED ADS | 7,964 | $725.2K | <0.1% | −368−4.4% | Reduced | History |
| CERTCertara, Inc. | COM | 81,740 | $809.2K | <0.1% | −10,389−11.3% | Reduced | History |
| BBNXBeta Bionics, Inc. | COM | 66,825 | $817.9K | <0.1% | +66,825 | New | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 15,550 | $823.7K | <0.1% | −8,046−34.1% | Reduced | History |
| PTGXProtagonist Therapeutics, Inc | COM | 17,622 | $852.2K | <0.1% | −6,096−25.7% | Reduced | History |
| SNYSanofi | SPONSORED ADR | 16,000 | $887.4K | <0.1% | +16,000 | New | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 195,052 | $1.03M | <0.1% | −182,754−48.4% | Reduced | History |
| VanEck ETF Trust92189F106 | GOLD MINERS ETF | 26,200 | $1.20M | <0.1% | 00.0% | Unchanged | – |
| RDYDr Reddys Laboratories Ltd | ADR | 91,916 | $1.21M | <0.1% | −5,984−6.1% | Reduced | History |
| SMMTSummit Therapeutics Inc. | COM | 67,685 | $1.31M | <0.1% | −102,909−60.3% | Reduced | History |
| DOCSDoximity, Inc. | CL A | 23,816 | $1.38M | <0.1% | −4,095−14.7% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 25,566 | $1.56M | <0.1% | −12,547−32.9% | Reduced | History |
| TXG10x Genomics, Inc. | CL A COM | 230,997 | $2.02M | <0.1% | −39,731−14.7% | Reduced | History |
| CVSCVS Health Corp | Stock | 31,755 | $2.15M | <0.1% | +9,911+45.4% | Added | History |
| ILMNIllumina, Inc. | COM | 27,624 | $2.19M | <0.1% | −16,079−36.8% | Reduced | History |
| CAHCardinal Health Inc | Stock | 20,776 | $2.86M | 0.1% | −1,522−6.8% | Reduced | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 40,000 | $2.94M | 0.1% | +4,300+12.0% | Added | History |
| PFEPfizer Inc | Stock | 120,746 | $3.06M | 0.1% | −20,814−14.7% | Reduced | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 91,191 | $3.09M | 0.1% | −76,150−45.5% | Reduced | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 5,660 | $3.17M | 0.1% | 00.0% | Unchanged | History |
| KMTSKestra Medical Technologies, Ltd. | SHS | 133,761 | $3.33M | 0.1% | +133,761 | New | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 221,715 | $3.84M | 0.1% | −263,335−54.3% | Reduced | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 61,261 | $3.89M | 0.1% | −507,694−89.2% | Reduced | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,733,547 | $4.24M | 0.1% | −5,784,292−67.9% | Reduced | History |
| BTSGBrightSpring Health Services, Inc. | COM | 241,749 | $4.37M | 0.1% | +67,597+38.8% | Added | History |
| ASTHAstrana Health, Inc. | COM NEW | 163,155 | $5.06M | 0.1% | −42,084−20.5% | Reduced | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 21,476 | $5.23M | 0.1% | −12,075−36.0% | Reduced | History |
| CNCCentene Corp | Stock | 86,218 | $5.23M | 0.1% | −238−0.3% | Reduced | History |
| ALTAltimmune, Inc. | COM NEW | 1,056,793 | $5.28M | 0.1% | +111,347+11.8% | Added | History |
| WAYWaystar Holding Corp. | COM | 144,426 | $5.40M | 0.1% | −13,472−8.5% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 55,926 | $5.50M | 0.1% | −4,949−8.1% | Reduced | History |
| EVHEvolent Health, Inc. | CL A | 614,337 | $5.82M | 0.1% | −499,321−44.8% | Reduced | History |
| CSTLCastle Biosciences Inc | COM | 301,103 | $6.03M | 0.1% | −444,879−59.6% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 55,022 | $6.17M | 0.1% | +6,593+13.6% | Added | History |
| LHLabcorp Holdings Inc. | Stock | 28,141 | $6.55M | 0.1% | +27,925+12,928.2% | Added | History |
| HUMHumana Inc | Stock | 28,298 | $7.49M | 0.2% | −69−0.2% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 149,113 | $9.52M | 0.2% | −22,204−13.0% | Reduced | History |
| PHRPhreesia, Inc. | COM | 376,163 | $9.61M | 0.2% | −29,530−7.3% | Reduced | History |
| ONCBeOne Medicines Ltd. | ADR | 35,329 | $9.62M | 0.2% | +1,100+3.2% | Added | History |
| ANNXAnnexon, Inc. | COM | 5,157,290 | $9.95M | 0.2% | 00.0% | Unchanged | History |
| IQVIQVIA Holdings Inc. | Stock | 61,068 | $10.8M | 0.2% | +16,235+36.2% | Added | History |
| JNJJohnson & Johnson | Stock | 67,009 | $11.1M | 0.2% | +12,452+22.8% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 96,407 | $11.2M | 0.3% | −22,523−18.9% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 150,550 | $11.5M | 0.3% | −107,933−41.8% | Reduced | History |
| NEONeogenomics Inc | COM NEW | 1,216,756 | $11.5M | 0.3% | +160,960+15.2% | Added | History |
| MASIMasimo Corp | COM | 69,808 | $11.6M | 0.3% | +45,642+188.9% | Added | History |
| TMDXTransMedics Group, Inc. | COM | 173,710 | $11.7M | 0.3% | −19,008−9.9% | Reduced | History |
| SIBNSI-BONE, Inc. | COM | 872,991 | $12.2M | 0.3% | −7,988−0.9% | Reduced | History |
| MGNXMacrogenics Inc | COM | 9,929,963 | $12.6M | 0.3% | 00.0% | Unchanged | History |
| THCTenet Healthcare Corp | COM NEW | 94,722 | $12.7M | 0.3% | −15,508−14.1% | Reduced | History |
| ESPREsperion Therapeutics, Inc. | COM | 9,694,064 | $14.0M | 0.3% | −250,000−2.5% | Reduced | History |
| BRKRBruker Corp | COM | 335,288 | $14.0M | 0.3% | −24,300−6.8% | Reduced | History |
| HOLXHologic Inc | COM | 247,886 | $15.3M | 0.3% | 00.0% | Unchanged | History |
| BAXBaxter International Inc | Stock | 456,446 | $15.6M | 0.4% | +456,446 | New | History |
| PRVAPrivia Health Group, Inc. | COM | 697,308 | $15.7M | 0.4% | −255,856−26.8% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 99,027 | $15.8M | 0.4% | −49,451−33.3% | Reduced | History |
| CDNACareDx, Inc. | COM | 889,003 | $15.8M | 0.4% | −485,409−35.3% | Reduced | History |
| NTRANatera, Inc. | COM | 113,219 | $16.0M | 0.4% | −32,457−22.3% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 40,058 | $17.4M | 0.4% | +1,715+4.5% | Added | History |
| EHCEncompass Health Corp | COM | 172,878 | $17.5M | 0.4% | −15,644−8.3% | Reduced | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 28,523 | $18.1M | 0.4% | −2,889−9.2% | Reduced | History |
| RLAYRelay Therapeutics, Inc. | COM | 7,377,292 | $19.3M | 0.4% | 00.0% | Unchanged | History |
| CORCencora, Inc. | Stock | 71,360 | $19.8M | 0.4% | −6,162−7.9% | Reduced | History |
| MCKMcKesson Corp | Stock | 30,580 | $20.6M | 0.5% | +11,265+58.3% | Added | History |
| MRKMerck & Co., Inc. | Stock | 231,371 | $20.8M | 0.5% | −32,855−12.4% | Reduced | History |
Sold out since Q4 2024 (22)
Positions held at the end of Q4 2024 that are gone from this filing.
| Security | Class | Shares in Q4 2024 | Value in Q4 2024 | % of portfolio in Q4 2024 | History |
|---|---|---|---|---|---|
| ITCIIntra-Cellular Therapies, Inc. | COM | 2,440,240 | $203.8M | 3.9% | History |
| ARVNArvinas, Inc. | COM | 2,389,600 | $45.8M | 0.9% | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 782,456 | $28.2M | 0.5% | History |
| SAGESage Therapeutics, Inc. | COM | 4,460,693 | $24.2M | 0.5% | History |
| CRLCharles River Laboratories International, Inc. | COM | 50,327 | $9.29M | 0.2% | History |
| FATEFate Therapeutics Inc | COM | 4,839,779 | $7.99M | 0.2% | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,061,753 | $5.88M | 0.1% | History |
| OMCLOmnicell, Inc. | COM | 94,740 | $4.22M | 0.1% | History |
| ACCDAccolade, Inc. | COM | 615,509 | $2.11M | <0.1% | History |
| GOOGAlphabet Inc. | Stock | 6,000 | $1.14M | <0.1% | History |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 100,414 | $795.3K | <0.1% | History |
| VKTXViking Therapeutics, Inc. | COM | 12,939 | $520.7K | <0.1% | History |
| XENEXenon Pharmaceuticals Inc. | COM | 8,200 | $321.4K | <0.1% | History |
| DNLIDenali Therapeutics Inc. | COM | 15,700 | $320.0K | <0.1% | History |
| ROIVRoivant Sciences Ltd. | SHS | 24,000 | $283.9K | <0.1% | History |
| BPMCBlueprint Medicines Corp | COM | 3,200 | $279.1K | <0.1% | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 4,000 | $168.3K | <0.1% | History |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 8,100 | $160.2K | <0.1% | History |
| NRIXNurix Therapeutics, Inc. | COM | 8,000 | $150.7K | <0.1% | History |
| VCYTVeracyte, Inc. | COM | 3,600 | $142.6K | <0.1% | History |
| KURAKura Oncology, Inc. | COM | 13,600 | $118.5K | <0.1% | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 41,500 | $97.5K | <0.1% | History |